|
2018, Volume 34, Number 3, Page(s) 225-233
|
|
DOI: 10.5146/tjpath.2018.01429 |
Recurrence in Uterine Tumors with Ovarian Sex-Cord Tumor Resemblance: A Case Report and Systematic Review |
Günsu KIMYON CÖMERT1, Çiğdem KILIÇ1, Deniz ÇAVUŞOĞLU2, Osman TÜRKMEN1, Alper KARALOK1, Taner TURAN1, Derman BAŞARAN1, Nurettin BORAN1 |
1Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women’s Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences , ANKARA, TURKEY 2Department of Pathology, Etlik Zubeyde Hanim Women’s Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences , ANKARA, TURKEY |
Keywords:
Uterine neoplasms, Recurrence, UTROSCT, Surgery, Prognosis |
Objective: The aim of this study was to evaluate the prognostic factors of recurrence in uterine tumors resembling ovarian sex-cord tumors
(UTROSCT) and to determine clinical-pathological characteristics, treatment options and outcome.
Material and Method: An electronic literature search was conducted from 1976 to 2018. After the comprehensive evaluation and conjunction
with our case, the study included 79 cases.
Results: The median age at initial diagnosis was 49 years (range; 16-86 years). The age was under 40 years in 21 (26.6%) patients. Whereas 68
patients underwent at least hysterectomy, 9 patients had organ sparing surgery. There was necrosis in 4 (5.1%) patients, atypia in 16 (20.3%)
patients, and infiltrative tumor border in 34 (43%) patients. At least one mitosis per 10 high power fields was determined in 36 (45.5%) patients.
The tumor involved at least part of the myometrium in 54 (68.3%) patients. Median follow-up time was 30 months (range; 3-296 months).
Recurrence was determined in 5 (6.3%) patients. The disease free survival (DFS) was significantly related only to surgery type. None of the
pathologic features were associated with DFS. The 5-year DFS was 86% and 96% in patients who underwent organ sparing surgery or not,
respectively (p=0.038).
Conclusion: The accurate pathologic diagnosis of UTROSCT has great value in shaping surgical management and management during the
follow-up period. Organ sparing surgery was related to poor DFS. Although recurrence is rare, it should be kept in mind for patients with
UTROSCT.
|
|
|
|